1 year return (CAGR)
-81.46%
NLS Pharmaceutics AG Exchange (NASDAQ, USD)
NLSP
-
+0.22 (+2.97%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
3.24M
Price/Sales
-
Ent value
13.15M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-6.11%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 7.70 |
| Daily high | 8.30 |
| Daily low | 7.60 |
| Daily Volume | 4.60M |
| 1y analyst estimate | 6.00 |
| Beta | 0.13 |
| EPS (TTM) | -2.30 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| NLSP | S&P500 | |
| Current price drop from All-time high | -99.67% | -1.10% |
| Highest price drop | -99.68% | -56.47% |
| Date of highest drop | 29 Oct 2025 | 9 Mar 2009 |
| Avg drop from high | -99.04% | -10.68% |
| Avg time to new high | - | 12 days |
| Max time to new high | 266 days | 1805 days |
News
No items found